[go: up one dir, main page]

AR119075A1 - Cápsulas blandas de liberación diferida - Google Patents

Cápsulas blandas de liberación diferida

Info

Publication number
AR119075A1
AR119075A1 ARP200101562A ARP200101562A AR119075A1 AR 119075 A1 AR119075 A1 AR 119075A1 AR P200101562 A ARP200101562 A AR P200101562A AR P200101562 A ARP200101562 A AR P200101562A AR 119075 A1 AR119075 A1 AR 119075A1
Authority
AR
Argentina
Prior art keywords
delayed release
soft capsules
release soft
fill material
composition
Prior art date
Application number
ARP200101562A
Other languages
English (en)
Inventor
Qi Fang
Karunakar Sukuru
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=73652472&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR119075(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of AR119075A1 publication Critical patent/AR119075A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Una cápsula blanda de liberación diferida que comprende lo siguiente: (a) un material de relleno y (b) una composición de la cubierta dependiente del pH, donde el material de relleno comprende al menos un ingrediente farmacéuticamente activo y donde la composición de la cubierta dependiente del pH comprende gelatina, pectina y dextrosa.
ARP200101562A 2019-06-03 2020-06-03 Cápsulas blandas de liberación diferida AR119075A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962856601P 2019-06-03 2019-06-03

Publications (1)

Publication Number Publication Date
AR119075A1 true AR119075A1 (es) 2021-11-24

Family

ID=73652472

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200101562A AR119075A1 (es) 2019-06-03 2020-06-03 Cápsulas blandas de liberación diferida

Country Status (14)

Country Link
US (1) US20220354800A1 (es)
EP (1) EP3976022A4 (es)
JP (1) JP7558204B2 (es)
KR (1) KR20220024189A (es)
CN (1) CN114072138A (es)
AR (1) AR119075A1 (es)
AU (2) AU2020288165B2 (es)
BR (1) BR112021024375A2 (es)
CA (1) CA3142702A1 (es)
CO (1) CO2021018071A2 (es)
IL (1) IL288653A (es)
MX (1) MX2021014922A (es)
TW (1) TW202110426A (es)
WO (1) WO2020247352A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220354800A1 (en) * 2019-06-03 2022-11-10 R.P. Scherer Technologies, Llc Delayed release softgel capsules
CN116528694A (zh) * 2020-06-02 2023-08-01 R.P.谢勒技术有限公司 延迟释放软凝胶胶囊
JP2023548711A (ja) * 2020-11-11 2023-11-20 アール．ピー．シェーラー テクノロジーズ，エルエルシー 遅延放出ソフトゲルカプセル
MX2023011596A (es) * 2021-04-01 2023-10-10 Scherer Technologies Llc R P Fosfolipidos como agentes quelantes de aniones en formulaciones farmaceuticas.
KR20240037990A (ko) * 2021-07-06 2024-03-22 알.피.쉐러 테크놀러지즈 엘엘씨 소프트겔 캡슐
US20250177312A1 (en) * 2022-02-18 2025-06-05 R.P. Scherer Technologies, Llc Modified release valproic acid softgel capsule
DE102022104553A1 (de) * 2022-02-25 2023-08-31 Gelita Ag Magensaftresistente Kapsel und deren Verwendung
CA3257517A1 (en) * 2022-06-13 2023-12-21 R.P. Scherer Technologies, Llc BISACODYL ENTERIC SOFT CAPSULE
JP2025537327A (ja) * 2022-11-23 2025-11-14 アール．ピー．シェーラー テクノロジーズ，エルエルシー ソフトゲルカプセル及びソフトゲルカプセルにマークを付ける方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
EP1184033A1 (en) * 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
US7255921B2 (en) * 2001-11-22 2007-08-14 Morishita Jintan Co., Ltd. Non-gelatinous capsule shell composition and a capsule formed from the same
AU2003301121A1 (en) * 2002-12-18 2004-07-14 Pain Therapeutics, Inc. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
CN101292965B (zh) 2007-04-24 2011-12-07 沈阳皓天万嘉医药科技有限公司 一种类β-胡萝卜素微囊及其制备方法
US20100159001A1 (en) * 2008-12-19 2010-06-24 Cardinal John R Extended-Release Pharmaceutical Formulations
CN101461792A (zh) * 2008-12-30 2009-06-24 吴国庆 明胶肠溶胶囊壳材料
WO2011014960A1 (en) * 2009-08-05 2011-02-10 7267207 Canada Limited Corporation Process for preparation of over-the-counter gelatin or pectin-based drug delivery
IT1401313B1 (it) * 2010-08-05 2013-07-18 Perfetti Van Melle Spa Caramelle gelatinose con ripieno fluido e metodo di ottenimento
US20120301546A1 (en) 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
CN102813275B (zh) * 2011-06-10 2015-09-30 杭州养生堂保健品有限公司 一种咀嚼型软胶囊皮和咀嚼型软胶囊
JP5876695B2 (ja) * 2011-09-29 2016-03-02 森下仁丹株式会社 シームレスカプセルおよびその製造方法
AR089441A1 (es) * 2011-12-22 2014-08-20 Baes Erik Capsulas de gelatina/alginato de liberacion retardada que comprenden acidos grasos omega-3 y metodos y usos de las mismas, metodo de manufactura, composicion farmaceutica
AU2014203942B2 (en) * 2013-01-05 2019-01-03 Anji Pharmaceuticals Inc. Delayed-release composition comprising biguanide
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
HUE053962T2 (hu) * 2014-09-11 2021-08-30 Gelita Ag Zselatin/pektin részecskék
EP3205339B1 (en) * 2014-10-06 2022-08-03 Fuji Capsule Co., Ltd. Method of manufacturing enteric seamless soft capsule
CN104644609B (zh) 2015-01-28 2017-06-16 龙标兵 一种功能性咀嚼型软胶囊皮
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
CN108578381A (zh) * 2018-02-27 2018-09-28 广州彤博士健康科技有限公司 可咀嚼性软胶囊外皮的配方及制备方法
US20220354800A1 (en) * 2019-06-03 2022-11-10 R.P. Scherer Technologies, Llc Delayed release softgel capsules

Also Published As

Publication number Publication date
CN114072138A (zh) 2022-02-18
CA3142702A1 (en) 2020-12-10
AU2020288165B2 (en) 2026-01-15
MX2021014922A (es) 2022-03-11
BR112021024375A2 (pt) 2022-04-19
WO2020247352A1 (en) 2020-12-10
US20220354800A1 (en) 2022-11-10
JP2022535539A (ja) 2022-08-09
AU2020288165A1 (en) 2022-01-06
AU2025279760A1 (en) 2026-01-15
EP3976022A1 (en) 2022-04-06
IL288653A (en) 2022-02-01
KR20220024189A (ko) 2022-03-03
EP3976022A4 (en) 2023-06-14
JP7558204B2 (ja) 2024-09-30
TW202110426A (zh) 2021-03-16
CO2021018071A2 (es) 2022-04-19

Similar Documents

Publication Publication Date Title
AR119075A1 (es) Cápsulas blandas de liberación diferida
CO2023007156A2 (es) Cápsulas de gel blando de liberación retardada
MX2019009777A (es) Sistemas y metodos para la fabricacion de tabletas, que incluyen tabletas farmaceuticas.
CO2022007168A2 (es) Cápsulas de gelatina blanda de liberación retardada en ambientes de ph más alto
AR115269A1 (es) Cápsulas de gelatina blanda entéricas
EP4480495A3 (en) Dual release dosage form capsule and methods, devices and systems for making same
CO2023007162A2 (es) Cápsulas de gelatina blanda de liberación retardada
MX2022002444A (es) Granulo recubierto, dispersion solida y preparacion que contiene hidrobromuro de vortioxetina enmascarante de sabor oral.
AR114434A1 (es) Cápsulas de gelatina blanda entéricas
UY31452A1 (es) Recubrimiento mejorado de tableta
CO2022001783A2 (es) Formulaciones de cápsulas de cubierta blanda y métodos de preparación y uso de las mismas
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
CL2021002107A1 (es) Triamtereno o nolatrexed para uso en el tratamiento de fenilcetonuria.
PH12019500919A1 (en) Esomeprazole~containing complex capsule and preparation method therefor
AR122512A1 (es) Cápsulas blandas de liberación retardada
CO2021015117A2 (es) Composición de naproxeno en cápsula blanda miniatura
MX2021002686A (es) Formulacion controlada de liberacion de farmacos.
MX2021009194A (es) Composiciones insecticidas resistentes a la degradación del ingrediente activo y proceso para la preparación de estas.
MX2021010338A (es) Composicion farmaceutica que contiene acetominofeno e ibuprofeno.
CO2023001954A2 (es) Cápsulas blandas de gelatina que incorporan formas de dosificación de liberación inmediata y extendida y métodos de fabricación
UY38496A (es) Aparato y proceso para el encapsulado secundario de inclusiones sólidas utilizando el proceso de matriz rotativa
MX394265B (es) Composiciones de encapsulacion.
MX2023005641A (es) Forma de dosificacion en capsula de gelatina blanda de talazoparib.
WO2020197101A3 (ko) 이중 약물 방출을 위한 약물 전달체
MX2020008813A (es) Forma de dosificacion farmaceutica para una emulsion de simeticona y loperamida.